You clearly are ignorant. I work in pharma com. Planning. P2 approval happens all the time in Oncology and rare disease where there is no risk given how little options these patients have. Yes it would be conditional approval and needs to be validated through p3
@triniblockchain @Brijesh7069 @Lionmaster not saying it’s out. I’m saying no fda approval Off P2, must complete P3 first
View original message